AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 119 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2017. The put-call ratio across all filers is 1.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $844,929 | -1.0% | 18,372 | +23.7% | 0.00% | – |
Q2 2023 | $853,315 | -1.0% | 14,848 | -35.4% | 0.00% | – |
Q1 2023 | $862,126 | +80.2% | 22,990 | +34.6% | 0.00% | – |
Q4 2022 | $478,414 | +10.2% | 17,074 | +10.5% | 0.00% | – |
Q3 2022 | $434,000 | -54.7% | 15,450 | -43.9% | 0.00% | – |
Q2 2022 | $958,000 | -4.4% | 27,536 | -1.3% | 0.00% | – |
Q1 2022 | $1,002,000 | +220.1% | 27,889 | +107.8% | 0.00% | – |
Q4 2021 | $313,000 | +77.8% | 13,418 | +44.9% | 0.00% | – |
Q3 2021 | $176,000 | -71.7% | 9,260 | -70.0% | 0.00% | – |
Q2 2021 | $623,000 | -19.0% | 30,887 | -26.4% | 0.00% | – |
Q1 2021 | $769,000 | -11.1% | 41,943 | -2.4% | 0.00% | – |
Q4 2020 | $865,000 | +170.3% | 42,981 | +152.1% | 0.00% | – |
Q3 2020 | $320,000 | -59.9% | 17,051 | -52.0% | 0.00% | – |
Q2 2020 | $798,000 | +74.2% | 35,542 | +15.1% | 0.00% | – |
Q1 2020 | $458,000 | -63.7% | 30,879 | -52.8% | 0.00% | – |
Q4 2019 | $1,262,000 | +0.3% | 65,464 | +3.1% | 0.00% | – |
Q3 2019 | $1,258,000 | +12.8% | 63,468 | +20.1% | 0.00% | – |
Q2 2019 | $1,115,000 | +27.7% | 52,836 | +23.7% | 0.00% | – |
Q1 2019 | $873,000 | +214.0% | 42,726 | +205.3% | 0.00% | – |
Q4 2018 | $278,000 | -3.8% | 13,996 | -6.9% | 0.00% | – |
Q3 2018 | $289,000 | +489.8% | 15,033 | +364.7% | 0.00% | – |
Q2 2018 | $49,000 | -62.6% | 3,235 | -53.4% | 0.00% | – |
Q1 2018 | $131,000 | +3.1% | 6,947 | +5.3% | 0.00% | – |
Q4 2017 | $127,000 | +54.9% | 6,595 | +44.5% | 0.00% | – |
Q3 2017 | $82,000 | -38.8% | 4,565 | -39.4% | 0.00% | – |
Q2 2017 | $134,000 | -1.5% | 7,529 | -19.5% | 0.00% | – |
Q1 2017 | $136,000 | -21.8% | 9,349 | -1.3% | 0.00% | – |
Q4 2016 | $174,000 | -33.1% | 9,474 | -30.8% | 0.00% | – |
Q3 2016 | $260,000 | +134.2% | 13,700 | +98.6% | 0.00% | – |
Q2 2016 | $111,000 | -52.6% | 6,900 | -64.6% | 0.00% | – |
Q1 2016 | $234,000 | -19.9% | 19,500 | -5.2% | 0.00% | – |
Q4 2015 | $292,000 | +1068.0% | 20,574 | +859.2% | 0.00% | – |
Q3 2015 | $25,000 | +177.8% | 2,145 | +329.0% | 0.00% | – |
Q2 2015 | $9,000 | -85.9% | 500 | -88.3% | 0.00% | – |
Q1 2015 | $64,000 | +2033.3% | 4,273 | +1765.9% | 0.00% | – |
Q4 2014 | $3,000 | – | 229 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Campbell & CO Investment Adviser LLC | 11,961 | $219,000 | 0.13% |
FEDERATED HERMES, INC. | 3,441,367 | $63,046,000 | 0.12% |
CORNERCAP INVESTMENT COUNSEL INC | 54,751 | $1,003,000 | 0.11% |
GSA CAPITAL PARTNERS LLP | 34,425 | $631,000 | 0.10% |
First Trust Direct Indexing L.P. | 11,913 | $218,000 | 0.06% |
Summit Global Investments | 47,546 | $871,000 | 0.06% |
WINTON GROUP Ltd | 49,766 | $912,000 | 0.05% |
FULLER & THALER ASSET MANAGEMENT, INC. | 397,950 | $7,290,000 | 0.05% |
AIGEN INVESTMENT MANAGEMENT, LP | 16,077 | $295,000 | 0.04% |
EXCHANGE TRADED CONCEPTS, LLC | 52,334 | $959,000 | 0.04% |